Apelin/APJ has been demonstrated to be involved in the development of hypercholesterolemia-associated atherosclerosis similarly to angiotensin II/AT1, which promotes endothelial dysfunction and myosin light chain phosphorylation in VSMCs [48,49,50,51]. The gene discussed is APLN; the disease is atherosclerosis.